Dreijerink KM - Search Results

1

Multiple endocrine neoplasia type 1: a chromatin writer's block.

Dreijerink KM, Lips CJ, Timmers HT. Dreijerink KM, et al. J Intern Med. 2009 Jul;266(1):53-9. doi: 10.1111/j.1365-2796.2009.02115.x. J Intern Med. 2009. PMID: 19522825 Free article. Review.

2

[Diverse expression of multiple endocrine neoplasia type 1].

Dreijerink KM, Roijers JF, Jansen-Schillhorn van Veen JM, Neijt JP, van Vroonhoven TJ, Lips CJ. Dreijerink KM, et al. Ned Tijdschr Geneeskd. 2000 Dec 16;144(51):2437-42. Ned Tijdschr Geneeskd. 2000. PMID: 11151650 Review. Dutch.

3

[Multiple endocrine neoplasia type 1: recent developments and guidelines for DNA diagnosis and periodic clinical monitoring].

Dreijerink KM, Roijers JF, van der Luijt RB, Höppener JW, Lips CJ. Dreijerink KM, et al. Ned Tijdschr Geneeskd. 2000 Dec 16;144(51):2445-9. Ned Tijdschr Geneeskd. 2000. PMID: 11151652 Review. Dutch.

4

Acromegaly in a multiple endocrine neoplasia type 1 (MEN1) family with low penetrance of the disease.

Dreijerink KM, van Beek AP, Lentjes EG, Post JG, van der Luijt RB, Canninga-van Dijk MR, Lips CJ. Dreijerink KM, et al. Eur J Endocrinol. 2005 Dec;153(6):741-6. doi: 10.1530/eje.1.02022. Eur J Endocrinol. 2005. PMID: 16322378

5

Menin links estrogen receptor activation to histone H3K4 trimethylation.

Dreijerink KM, Mulder KW, Winkler GS, Höppener JW, Lips CJ, Timmers HT. Dreijerink KM, et al. Cancer Res. 2006 May 1;66(9):4929-35. doi: 10.1158/0008-5472.CAN-05-4461. Cancer Res. 2006. PMID: 16651450

6

Mechanisms of disease: multiple endocrine neoplasia type 1-relation to chromatin modifications and transcription regulation.

Dreijerink KM, Höppener JW, Timmers HM, Lips CJ. Dreijerink KM, et al. Nat Clin Pract Endocrinol Metab. 2006 Oct;2(10):562-70. doi: 10.1038/ncpendmet0292. Nat Clin Pract Endocrinol Metab. 2006. PMID: 17024155 Review.

7

The multiple endocrine neoplasia type 1 (MEN1) tumor suppressor regulates peroxisome proliferator-activated receptor gamma-dependent adipocyte differentiation.

Dreijerink KM, Varier RA, van Beekum O, Jeninga EH, Höppener JW, Lips CJ, Kummer JA, Kalkhoven E, Timmers HT. Dreijerink KM, et al. Mol Cell Biol. 2009 Sep;29(18):5060-9. doi: 10.1128/MCB.01001-08. Epub 2009 Jul 13. Mol Cell Biol. 2009. PMID: 19596783 Free PMC article.

8

Tissue selectivity in multiple endocrine neoplasia type 1-associated tumorigenesis.

Gracanin A, Dreijerink KM, van der Luijt RB, Lips CJ, Höppener JW. Gracanin A, et al. Among authors: dreijerink km. Cancer Res. 2009 Aug 15;69(16):6371-4. doi: 10.1158/0008-5472.CAN-09-0678. Epub 2009 Aug 4. Cancer Res. 2009. PMID: 19654304 Review.

9

Regulation of vitamin D receptor function in MEN1-related parathyroid adenomas.

Dreijerink KM, Varier RA, van Nuland R, Broekhuizen R, Valk GD, van der Wal JE, Lips CJ, Kummer JA, Timmers HT. Dreijerink KM, et al. Mol Cell Endocrinol. 2009 Dec 10;313(1-2):1-8. doi: 10.1016/j.mce.2009.08.020. Epub 2009 Sep 1. Mol Cell Endocrinol. 2009. PMID: 19729047 Free article.

10

Diagnosis and Management of Multiple Endocrine Neoplasia Type 1 (MEN1).

Dreijerink KM, Lips CJ. Dreijerink KM, et al. Hered Cancer Clin Pract. 2005 Feb 15;3(1):1-6. doi: 10.1186/1897-4287-3-1-1. Hered Cancer Clin Pract. 2005. PMID: 20223025 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

89 results

Search Page

Filters